ACLX
Arcellx, Inc.
NASDAQ · Healthcare · Biotechnology · US
$115.07
+0.02%Latest reported
- Last report date
- Nov 5, 2025
- EPS actual
- -$0.99
- EPS estimate
- -$0.96
- Revenue actual
- $4.9M
- Revenue estimate
- $12.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -16.8%
- Revenue beats (12Q)
- 3
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 7, 2026